Dear friends of the A-T Children’s Project,

I’m reaching out to you, because I wanted to make sure that all of our supporters, regardless of their location around the globe, were aware of a unique event we’re hosting in Boston, Massachusetts on May 11th. Dubbed “ILLUMINATION: A BioPharma Leadership Ball,” our extraordinary evening will unfold at the Museum of Fine Arts, an elegant venue housing over half a million works of art spanning ancient treasures to modern masterpieces.

Besides raising funds for research, our aim for the evening is to bring together biotechnology and pharmaceutical company leaders and their investors and to inspire them to channel their expertise and breakthrough technologies towards developing urgently needed treatments for our kids’ disease (ataxia telangiectasia).

To help us draw senior-level decision makers, an amazing group of industry leaders and investors are graciously co-hosting the event for us. It means the world to A-T families to know that these luminaries want to help. And we’ve already heard from individuals who will be coming from distant locations to spend a weekend in Boston, just to join an evening of celebration and hope for A-T families like mine, while strengthening friendships with industry friends.

If there’s a chance that you can join our evening of fine dining, stimulating conversation, indulgent desserts, and spirited dancing, please visit www.atcp.org/ball. And to those of you who’ve already secured sponsorships, tables or tickets, a heartfelt thank you. I’m looking forward to seeing you soon! For those unable to join in person, your support for this event would still be invaluable.

Should you have any questions about the event, please don’t hesitate to contact either me or Jennifer Thornton, Executive Director of the A-T Children’s Project, at jennifer@atcp.org.

All the best,

Brad Margus

Founder and Volunteer Board Chair

Related News

May 22 @ 9:45 am

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

more
May 22 @ 9:45 am

Measles Prevention in A-T: Recommendations from Dr. Lederman

Dr. Lederman of the A-T Clinical Center provides recommendations to keep people with A-T from catching measles.

more
May 22 @ 9:45 am

Looking Forward to Research Advances in 2024

As 2023 is wrapping up, we want to thank all of you who support the A-T Children’s Project

more
May 22 @ 9:45 am

A-T Biomarker Development Initiative Now Recruiting

On December 18, the A-T Children’s Project sent out the below email to A-T parents in the United…

more